IGF2 and cancer: In particular, the level and relative quantification of cancer-specific (big)IGF-II can be made possible upon long-read transcript sequencing scouting for the retention of the exon regions coding for the IGF2 D and E domains bearing the glycosylation sites responsible for the glyco-moiety present in its high molecular variants [9].